<SEC-DOCUMENT>0002050755-25-000017-index.html : 20251017
<SEC-HEADER>0002050755-25-000017.hdr.sgml : 20251017
<ACCEPTANCE-DATETIME>20251017183303
ACCESSION NUMBER:		0002050755-25-000017
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251015
FILED AS OF DATE:		20251017
DATE AS OF CHANGE:		20251017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hoffman Reid
		CENTRAL INDEX KEY:			0001519339
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39979
		FILM NUMBER:		251401935

	MAIL ADDRESS:	
		STREET 1:		179 STARR DRIVE
		CITY:			EASTSOUND
		STATE:			WA
		ZIP:			98245

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Reprogrammed Interchange LLC
		CENTRAL INDEX KEY:			0002050755
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39979
		FILM NUMBER:		251401936

	BUSINESS ADDRESS:	
		STREET 1:		101 MISSION STREET, SUITE 1000
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105
		BUSINESS PHONE:		415-541-0200

	MAIL ADDRESS:	
		STREET 1:		101 MISSION STREET, SUITE 1000
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94105

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vor Biopharma Inc.
		CENTRAL INDEX KEY:			0001817229
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				811591163
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		SUITE 1350
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-655-6580

	MAIL ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		SUITE 1350
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-10172025_101057.xml
<TEXT>
Document 1 - file: form4-10172025_101057.html

Document 1 - RAW XML: form4-10172025_101057.xml

</DOCUMENT>
</SEC-DOCUMENT>